Medicaid cuts passed by Congress will reduce federal spending by roughly $700 billion over the next decade1 — the largest contraction since the program’s inception — with implementation and impact varying by state. Policy measures include tighter eligibility rules, lower federal matching rates, and restrictions on the hospital and nursing home payments eligible for federal reimbursement.
The human costs are significant: loss of coverage for millions, delayed care, and worsening health outcomes. And the business implications compound the social consequences.
Healthcare companies built on Medicaid revenue face simultaneous pressures that create strategic challenges. Providers will lose both patient volume and reimbursement rates, yet they must still absorb the cost of uncompensated emergency care. Life sciences companies will see addressable markets shrink as more than 37 million children2 and millions of long-term care patients lose coverage. Investors with exposure to Medicaid-dependent assets may need to reprice entire portfolios.
Even as revenues contract, federal healthcare fraud enforcement is expanding. Companies facing revenue pressure may be tempted to reduce compliance spending precisely when billing practices face heightened scrutiny. In this uncertain environment, choices about what to scale back and what to safeguard will determine which business models remain viable as public funding recedes.
* * *
Download the Forces of Law report now to read the full article and gain access to our complete collection of insights exploring legal forces reshaping modern business strategy.
-
[1] “Estimated Budgetary Effects of a Bill to Provide for Reconciliation Pursuant to Title II of H. Con. Res. 14, the One Big Beautiful Bill Act,” Congressional Budget Office (May 2025), summarized in “Projected Health System and Economic Impacts of 2025 Medicaid Policy Proposals,” JAMA Health Forum (July 2025) and “Allocating CBO’s Estimates of Federal Medicaid Spending Reductions and Enrollment Loss Across the States: House Reconciliation Bill” KFF (June 2025). ↩
-
[2] “State Medicaid and CHIP Applications, Eligibility Determinations, and Enrollment Data,” Data.Medicaid.gov (accessed June 2025). ↩
This informational piece, which may be considered advertising under the ethical rules of certain jurisdictions, is provided on the understanding that it does not constitute the rendering of legal advice or other professional advice by Goodwin or its lawyers. Prior results do not guarantee similar outcomes.
Contacts
- /en/people/a/albala-ilene

Ilene Albala
Partner - /en/people/m/medina-allan

Allan Medina
Partner - /en/people/g/goodman-andi

Andi Goodman
Associate - /en/people/j/jandl-samantha

Samantha Jandl
Associate

